DF-4001

N/A

Report date: 2024/01/02 13:47:49

Base Information

Drug NameDF-4001
Drug Alias NameDF-4001DF4001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDragonfly Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesDragonfly Therapeutics LlcBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A